Shares of Healthequity Inc (NASDAQ:HQY) have earned an average rating of “Buy” from the fourteen brokerages that are covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation and two have given a strong buy recommendation to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $77.90.
A number of brokerages recently commented on HQY. Citigroup raised their price objective on shares of Healthequity from $58.00 to $68.00 and gave the company an “outperform” rating in a research report on Tuesday, March 20th. Cantor Fitzgerald restated a “hold” rating and issued a $68.00 price objective (up previously from $65.00) on shares of Healthequity in a research report on Monday, June 4th. Zacks Investment Research downgraded shares of Healthequity from a “buy” rating to a “hold” rating in a research report on Saturday, May 12th. Robert W. Baird increased their target price on shares of Healthequity from $61.00 to $77.00 and gave the company a “neutral” rating in a report on Tuesday, June 5th. Finally, SunTrust Banks increased their target price on shares of Healthequity to $70.00 and gave the company a “buy” rating in a report on Tuesday, March 20th.
In other news, EVP Gary D. Robinson sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, April 5th. The shares were sold at an average price of $63.85, for a total transaction of $95,775.00. Following the completion of the transaction, the executive vice president now directly owns 4,490 shares of the company’s stock, valued at approximately $286,686.50. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Angelique Christine Hill sold 8,000 shares of the firm’s stock in a transaction that occurred on Friday, June 8th. The stock was sold at an average price of $77.45, for a total transaction of $619,600.00. Following the transaction, the vice president now directly owns 18,471 shares of the company’s stock, valued at $1,430,578.95. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 478,790 shares of company stock valued at $33,070,800. 4.00% of the stock is currently owned by corporate insiders.
Institutional investors and hedge funds have recently modified their holdings of the company. Citigroup Inc. increased its stake in shares of Healthequity by 414.4% during the 1st quarter. Citigroup Inc. now owns 2,639 shares of the company’s stock worth $160,000 after purchasing an additional 2,126 shares in the last quarter. WINTON GROUP Ltd purchased a new position in shares of Healthequity during the 1st quarter worth approximately $206,000. M&T Bank Corp purchased a new position in shares of Healthequity during the 1st quarter worth approximately $206,000. Parametrica Management Ltd purchased a new position in shares of Healthequity during the 1st quarter worth approximately $220,000. Finally, Zions Bancorporation purchased a new position in shares of Healthequity during the 1st quarter worth approximately $220,000. 96.58% of the stock is owned by institutional investors and hedge funds.
NASDAQ:HQY traded down $2.88 during mid-day trading on Friday, reaching $74.21. The stock had a trading volume of 718,029 shares, compared to its average volume of 611,349. The company has a market cap of $4.77 billion, a P/E ratio of 137.43, a PEG ratio of 3.20 and a beta of 1.42. Healthequity has a twelve month low of $40.21 and a twelve month high of $82.04.
Healthequity (NASDAQ:HQY) last announced its quarterly earnings data on Monday, June 4th. The company reported $0.31 EPS for the quarter, beating the Zacks’ consensus estimate of $0.22 by $0.09. The firm had revenue of $69.90 million during the quarter, compared to the consensus estimate of $68.81 million. Healthequity had a net margin of 22.91% and a return on equity of 13.47%. The firm’s revenue was up 26.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.23 earnings per share. analysts predict that Healthequity will post 0.72 earnings per share for the current fiscal year.
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.